C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/70 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07F 7/18 (2006.01) C07H 19/04 (2006.01) C07H 19/06 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07H 23/00 (2006.01)
Patent
CA 2103464
2103464 9220823 PCTABS00017 Therapeutic oligonucleotide analogs which have improved nuclease resistance and improved cellular uptake are provided. Replacement of phosphorodiester inter-sugar linkages found in wild type oligomers with four atom linking groups forms unique di- and poly-nucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
Cook Phillip Dan
de Mesmaeker Alain
Lebreton Jacques
Waldner Adrian
Isis Pharmaceuticals Inc.
Novartis Ag
Swabey Ogilvy Renault
LandOfFree
Backbone modified oligonucleotide analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Backbone modified oligonucleotide analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Backbone modified oligonucleotide analogs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1856568